Gilteritinib maintenance after allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute myeloid leukemia with FLT3-internal tandem duplication mutation

Background: Patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) with FLT3-Internal Tandem Duplication (ITD) mutation have a poor prognosis and high risk of relapse, even after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Prevention of disease relapse remains a...

全面介紹

書目詳細資料

Principais autores:	Chen Liang, Donglin Yang, Aiming Pang, Yi He, Rongli Zhang, Weihua Zhai, Sizhou Feng, Mingzhe Han, Suning Chen, Liping Dou, Yu Wang, Xiaojin Wu, Erlie Jiang
格式:	Artigo
語言:	Inglês
出版:	Taylor & Francis Group 2025-12-01
叢編:	Hematology
主題:	Acute myeloid leukemia FLT3-ITD hematopoietic stem cell transplantation relapsed/refractory disease FLT3 inhibitor Gilteritinib
在線閱讀:	https://www.tandfonline.com/doi/10.1080/16078454.2025.2509353
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!